companydata.dkcompanydata.dk

GlyProVac ApS: Financial statements 2023

CVR: 39724758

Source: annual report 2023, Danish Business Authority

01/07/2022 – 30/06/2023

GlyProVac ApS (CVR 39724758) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -814,748 and a net result of DKK -2,871,688 compared with DKK -633,455 the year before. Equity in the 2023 report amounted to DKK 851,577. The solvency ratio was 15.4%. The company had 4 employees in the financial year.

Gross Profit
DKK -814,748
Profit/Loss
DKK -2,871,688
Equity
DKK 851,577
Total Assets
DKK 5,513,113
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--815 t.-2.9 mio.852 t.4
2022-1.3 mio.-633 t.5 mio.4
2021-993 t.-487 t.2.4 mio.3
2020-1.1 mio.-699 t.672 t.4
2019-145 t.-918 t.1.4 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Kirsten Winther joins the board of GlyProVac ApSOct 5, 2023

As of October 5, 2023, Kirsten Winther has joined the board of directors of GlyProVac ApS.

Tommi Petteri Kainu joins the board of GlyProVac ApSOct 5, 2023

As of October 5, 2023, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.

Kirsten Winther leaves the board of GlyProVac ApSOct 4, 2023

As of October 4, 2023, Kirsten Winther has left the board of directors of GlyProVac ApS.

Tommi Petteri Kainu leaves the board of GlyProVac ApSOct 4, 2023

As of October 4, 2023, Tommi Petteri Kainu has left the board of directors of GlyProVac ApS.

Rossi Finans ApS registered as owner of GlyProVac ApSSep 28, 2023

As of September 28, 2023, Rossi Finans ApS is registered as an owner of GlyProVac ApS with an ownership share of 10%.

About GlyProVac ApS

GlyProVac ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Anders Boysen and Ann Zahle Andersen. The board consists of Ann Zahle Andersen (chair), Allan Rosetzsky, Kirsten Winther and Willem Adriaan de Jongh. The company's owners include Bente Kristiansen, Rossi Finans ApS and I/S Rødeledsvej. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -2,128,863 and a net result of DKK -5,168,999 compared with DKK -3,014,952 the year before. Equity in the 2025 report amounted to DKK -831,720.

Source: annual report 2025, Danish Business Authority

Other financial years